×
Sanofi Revenue 2012-2026 | SNY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Sanofi revenue for the twelve months ending March 31, 2026 was
$54.841B
, a
16.62% increase
year-over-year.
Sanofi annual revenue for 2025 was
$52.854B
, a
10.29% increase
from 2024.
Sanofi annual revenue for 2024 was
$47.922B
, a
4.66% decline
from 2023.
Sanofi annual revenue for 2023 was
$50.266B
, a
5.11% increase
from 2022.
View More
Sanofi Revenue 2012-2026 | SNY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Sanofi annual revenue for 2025 was
$52.854B
, a
10.29% increase
from 2024.
Sanofi annual revenue for 2024 was
$47.922B
, a
4.66% decline
from 2023.
Sanofi annual revenue for 2023 was
$50.266B
, a
5.11% increase
from 2022.
Related Stocks
Company Name
Market
Cap
Eli Lilly and Company (LLY)
$1T
Johnson & Johnson (JNJ)
$556.8B
AbbVie Inc. (ABBV)
$406.4B
Roche Holding AG (RHHBY)
$312.9B
Merck & Co., Inc. (MRK)
$285.2B
Novartis AG (NVS)
$284.2B
Novo Nordisk A/S (NVO)
$204.9B
Pfizer Inc. (PFE)
$142.9B
Bayer Aktiengesellschaft (BAYRY)
$42.5B
Innoviva, Inc. (INVA)
$1.7B